Furthermore, Masuda et al. and Aggarwal et al. showed that EGCG inhibits the activation of NF-kB in head and neck cancer, breast cancer and colon cancer and it is involved in the NF-kB signaling pathway [55,56]. This evidence concerns the gene NFKB1 and breast cancer.